Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
Sebastian E Sattui,Richard Conway,Michael S Putman,Andrea M Seet,Milena A Gianfrancesco,Kaley Beins,Catherine Hill,David Liew,Sarah L Mackie,Puja Mehta,Lorna Neill,Gimena Gomez,Maria Isabel Haye Salinas,Federico Nicolas Maldonado,Henrique Ataide Mariz,Samia Araujo de Sousa Studart,Nafice Costa Araujo,Ann Knight,Davide Rozza,Luca Quartuccio,Maxime Samson,Stéphane Bally,Alexandre Tj Maria,Pascal Chazerain,Rebecca Hasseli,Ulf Müller-Ladner,Bimba F Hoyer,Reinhard Voll,Rita Pinheiro Torres,Mariana Luis,Sandra Lucia Euzebio Ribeirio,Samar Al-Emadi,Jeffrey A Sparks,Tiffany Y-T Hsu,Kristin M D'Silva,Naomi J Patel,Leanna Wise,Emily Gilbert,Maria Valenzuela Almada,Alí Duarte-García,Manuel Ugarte-Gil,Lindsay Jacobsohn,Zara Izadi,Anja Strangfeld,Elsa F Mateus,Kimme L Hyrich,Laure Gossec,Loreto Carmona,Saskia Lawson-Tovey,Lianne Kearsley-Fleet,Martin Schaefer,Emily Sirotich,Jonathan S Hausmann,Paul Sufka,Suleman Bhana,Jean W Liew,Rebecca Grainger,Pedro M Machado,Zachary S Wallace,Jinoos Yazdany,Philip C Robinson,Global Rheumatology Alliance,Brahim Dahou,Eva Rath,Yves Piette,Mieke Devinck,Bea Maeyaert,Francinne Machado Ribeiro,Sandra Lucia Euzebio Ribeiro,Marcelo Pinheiro,Rosana Quintana,Gimena Gómez,Karen Roberts,Roberto Miguel Baez,Vanessa Castro Coello,María J Haye Salinas,Alvaro Andres Reyes Torres,Gelsomina Alle,Romina Tanten,Hernán Maldonado Ficco,Romina Nieto,Carla Gobbi,Yohana Tissera,Cecilia Pisoni,Alba Paula,Juan Alejandro Albiero,Maria Marcela Schmid,Micaela Cosatti,Maria Julieta Gamba,Carlevaris Leandro,María Alejandra Cusa,Noelia German,Veronica Bellomio,Lorena Takashima,Mariana Pera,Karina Cogo,Maria Soledad Gálvez Elkin,María Alejandra Medina,Veronica Savio,Ivana Romina Rojas Tessel,Rodolfo Perez Alamino,Marina Laura Werner,Sofía Ornella,Luciana Casalla,Maria de la Vega,María Severina,Mercedes García,Luciana Gonzalez Lucero,Cecilia Romeo,Sebastián Moyano,Tatiana Barbich,Ana Bertoli,Andrea Baños,Sandra Petruzzelli,Carla Matellan,Silvana Conti,Ma Alicia Lazaro,Gustavo Fabián Rodriguez Gil,Fabian Risueño,Maria Isabel Quaglia,Julia Scafati,Natalia Lili Cuchiaro,Jonathan Eliseo Rebak,Susana Isabel Pineda,María Elena Calvo,Eugenia Picco,Josefina Gallino Yanzi,Pablo Maid,Debora Guaglianone,Julieta Silvana Morbiducci,Sabrina Porta,Natalia Herscovich,José Luis Velasco Zamora,Boris Kisluk,Maria Sol Castaños Menescardi,Rosana Gallo,María Victoria Martire,Carla Maldini,Cecilia Goizueta,Sabrina Solange de la Vega Fernandez,Carolina Aeschlimann,Gisela Subils,Sebastián Ibáñez,Anne-Marie Chassin-Trubert,Lingli Dong,Lui Cajas,Marko Barešic,Branimir Anic,Melanie-Ivana Culo,Tea Ahel Pavelic,Kristina Kovacevic Stranski,Boris Karanovic,Jiri Vencovsky,Marta Píchová,Maria Filkova,Hesham Hamoud,Dimitrios Vassilopoulos,Gabriela Maria Guzman Melgar,Ho So,Márta Király,Mahdi Vojdanian,Alexandra Balbir-Gurman,Fatemah Abutiban,Julija Zepa,Inita Bulina,Loreta Bukauskiene,Beatriz Zaueta,Angel Alejandro Castillo Ortiz,Erick Zamora Tehozol,David Vega,Diana Cervántes Rosete,Eduardo Martín Nares,Tatiana Sofia Rodriguez-Reyna,Marina Rull Gabayet,Deshiré Alpízar-Rodríguez,Fedra Irazoque,Xochitl Jimenez,Lenny Geurts-van Bon,Theo Zijlstra,Monique Hoekstra,Nasra Al-Adhoubi,Babur Salim,Enrique Giraldo,Ariel Salinas,Jaroslaw Nowakowski,Rachael Flood,Geraldine McCarthy,Ioana Felea,Ileana Filipescu,Simona Rednic,Laura Groseanu,Maria Magdelena Tamas,Vanda Mlynarikova,Martina Skamlova,Martin Zlnay,Dagmar Miceková,Lubica Capova,Zelmira Macejova,Emoke Štenová,Helena Raffayova,Gabriela Belakova,Eva Strakova,Marieta Sencarová,Sona Žlnayová,Anna Anna Sabová,Daniela Spisakova,Mária Oetterová,Olga Lukacova,Martina Bakosova,Alojzija Hocevar,Natalia de la Torre-Rubio,Juan José Alegre Sancho,Montserrat Corteguera Coro,Juan Carlos Cobeta Garcia,Maria Carmen Torres Martin,Jose Campos,Jose A Gomez Puerta,Gozd Kubra Yardimci,Servet Akar,Ozan Cemal Icacan,Selda Çelik,Viktoriia Vasylets,Su-Ann Yeoh,Claire Vandevelde,Sasha Dunt,Jane Leeder,Elizabeth Macphie,Rosaria Salerno,Christine Graver,Katie Williams,Sheila O'Reilly,Kirsty Devine,Jennifer Tyler,Elizabeth Warner,James Pilcher,Samir Patel,Elena Nikiphorou,Laura Chadwick,Caroline Mulvaney Jones,Beverley Harrison,Lucy Thornton,Diana O'Kane,Lucia Fusi,Audrey Low,Sarah Horton,Shraddha Jatwani,Sara Baig,Hammad Bajwa,Vernon Berglund,Angela Dahle,Walter Dorman,Jody Hargrove,Maren Hilton,Nicholas Lebedoff,Susan Leonard,Jennifer Morgan,Emily Pfeifer,Archibald Skemp,Jeffrey Wilson,Anne Wolff,Eduardo Cepeda,Kristin D'Silva,Tiffany Hsu,Naomi Patel,Jeffrey Sparks,Derrick Todd,Zachary Wallace,Denise Hare,Cassandra Calabrese,Christopher Adams,Arezou Khosroshahi,Adam Kilian,Douglas White,Melanie Winter,Theodore Fields,Caroline Siegel,Nicole Daver,Melissa Harvey,Neil Kramer,Concetta Lamore,Suneya Hogarty,Karen Yeter,Faizah Siddique,Byung Ban,Tamar Tanner,Eric Ruderman,William Davis,Robert Quinet,Evangeline Scopelitis,Karen Toribio Toribio,Tameka Webb-Detiege,Jerald Zakem,Khurram Abbass,Gilbert Kepecs,Lilliam Miranda,Michael Guma,Ammar Haikal,Sushama Mody,Daric Mueller,Arundathi Jayatilleke,JoAnn Zell,Alison Bays,Kathryn Dao,Ezzati Fatemeh,Deborah Parks,David Karp,Guillermo Quiceno
DOI: https://doi.org/10.1016/S2665-9913(21)00316-7
Abstract:Background: Patients with primary systemic vasculitis or polymyalgia rheumatica might be at a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ damage cause by primary systemic vasculitis, and the demographic factors associated with these conditions. We therefore aimed to investigate factors associated with COVID-19 outcomes in patients with primary systemic vasculitis or polymyalgia rheumatica. Methods: In this retrospective cohort study, adult patients (aged ≥18 years) diagnosed with COVID-19 between March 12, 2020, and April 12, 2021, who had a history of primary systemic vasculitis (antineutrophil cytoplasmic antibody [ANCA]-associated vasculitis, giant cell arteritis, Behçet's syndrome, or other vasculitis) or polymyalgia rheumatica, and were reported to the COVID-19 Global Rheumatology Alliance registry were included. To assess COVID-19 outcomes in patients, we used an ordinal COVID-19 severity scale, defined as: (1) no hospitalisation; (2) hospitalisation without supplemental oxygen; (3) hospitalisation with any supplemental oxygen or ventilation; or (4) death. Multivariable ordinal logistic regression analyses were used to estimate odds ratios (ORs), adjusting for age, sex, time period, number of comorbidities, smoking status, obesity, glucocorticoid use, disease activity, region, and medication category. Analyses were also stratified by type of rheumatic disease. Findings: Of 1202 eligible patients identified in the registry, 733 (61·0%) were women and 469 (39·0%) were men, and their mean age was 63·8 years (SD 17·1). A total of 374 (31·1%) patients had polymyalgia rheumatica, 353 (29·4%) had ANCA-associated vasculitis, 183 (15·2%) had giant cell arteritis, 112 (9·3%) had Behçet's syndrome, and 180 (15·0%) had other vasculitis. Of 1020 (84·9%) patients with outcome data, 512 (50·2%) were not hospitalised, 114 (11·2%) were hospitalised and did not receive supplemental oxygen, 239 (23·4%) were hospitalised and received ventilation or supplemental oxygen, and 155 (15·2%) died. A higher odds of poor COVID-19 outcomes were observed in patients who were older (per each additional decade of life OR 1·44 [95% CI 1·31-1·57]), were male compared with female (1·38 [1·05-1·80]), had more comorbidities (per each additional comorbidity 1·39 [1·23-1·58]), were taking 10 mg/day or more of prednisolone compared with none (2·14 [1·50-3·04]), or had moderate, or high or severe disease activity compared with those who had disease remission or low disease activity (2·12 [1·49-3·02]). Risk factors varied among different disease subtypes. Interpretation: Among patients with primary systemic vasculitis and polymyalgia rheumatica, severe COVID-19 outcomes were associated with variable and largely unmodifiable risk factors, such as age, sex, and number of comorbidities, as well as treatments, including high-dose glucocorticoids. Our results could be used to inform mitigation strategies for patients with these diseases. Funding: American College of Rheumatology and the European Alliance of Associations for Rheumatology.